drugset / Trial / NCT00643799

Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis

NCT00643799

Phase 4 Completed 586 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the safety and efficacy of celecoxib versus naproxen for the treatment of knee osteoarthritis

Timeline

Start
2004-03
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Comparator Naproxen Small molecule 500 mg Oral

Indications